Pradžia › Migrena › Merilendas
Migrena klinikiniai tyrimai Merilendas
7 tyrimai dėl Migrena ieško dalyvių vietose Merilendas.
Miestai Merilendas
Oficialus tyrimo tekstas (anglų kalba)
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 8 iki 70 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05669703Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pharmasite Research, Inc. /ID# 227908, Baltimore
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-14 · NCT05125302Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine
- Johns Hopkins Medicine, Baltimore
Renkami dalyviai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07223008A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- MedStar Health Research Institute, Olney
Renkami dalyviai
Amžius nuo 22 iki 84 · Visoms lytims · Atnaujinta 2026-08-28 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Headlands Research - PharmaSite, Pikesville
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- University of Maryland School of Medicine, Baltimore
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-06-12 · NCT05164172Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
- National Intrepid Center of Excellence (NICOE), Bethesda
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-12-05 · NCT07267819Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.